Natural product-based therapy for Pulmonary Hypertension (PAH): Agaricus blazei Murill inhibits pulmonary hypertension via induction of PDLIM5, 7/February/2015, 07.50 am

Regulation of tRNA synthesis: Ras-responsive element-binding protein 1 (RREB) increases the expression of RNA polymerase III via down regulation of its target gene, 7/February/2015, 07.40 am
February 7, 2015
Natural product-based therapy for B-cell cancer: Cirsilol (3′,4′,5-trihydroxy-6,7-dimethoxyflavone), a flavone isolated from Achillea fragrantissima, suppresses the expression of FOXP1 and inhibits Wnt/β-catenin signalling via up regulation of its target gene, 07/February/2015, 07.55 am
February 7, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests, for the first time, that Agaricus blazei Murill, by suppressing the expression of its target gene, it may increase the expression of PDLIM5. Thereby, it may inhibit pulmonary hypertension. Together, pharmacological formulations encompassing “Agaricus blazei Murill or small molecule compounds isolated from Agaricus blazei Murill may be used to treat pulmonary arterial hypertension (PAH).

Amount: $ 500*

Undisclosed information: How Agaricus blazei Murill  increases the expression of PDLIM5

To citeBoominathan, Natural product-based therapy for Pulmonary Hypertension (PAH): Agaricus blazei Murill inhibits pulmonary hypertension via induction of PDLIM5, 7/February/2015,  07.50 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.